Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling
- PMID: 16174886
- DOI: 10.1385/NCC:3:2:153
Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling
Abstract
Objective and importance: Current applications of lytic therapy for intraventricular hemorrhage (IVH) rely on exclusion of vascular abnormalities as etiology. Its use in patients with recently coiled aneurysms remains far from considered safe. We report a patient with subarachnoid hemorrhage (SAH) and massive IVH from aneurysmal rupture, which was safely treated with intraventricular recombinant tissue plasminogen activator (rt-PA) after endovascular coiling. We also review two other similar cases reported in the literature.
Clinical presentation: A 61-year-old man presented with a ruptured anterior communicating artery aneurysm causing SAH and IVH (Hunt & Hess grade IV, Fisher grade III with IVH). During coiling of the aneurysm, extravasation of contrast was noted on fluoroscopy. Follow-up head computed tomography (CT) scan showed casted ventricles. Once in the intensive care unit, the patient progressed to coma, which did not improve with external ventricular drainage alone.
Intervention: After endovascular coiling of the aneurysm, intraventricular rt-PA was administered. Isovolemic injections of 2 mg rt-PA every 12 hours were performed for a total of four doses. No clinical or radiological evidence of worsening SAH/IVH was documented. At the time of discharge, the patient was awake but requiring assistance with activities of daily living.
Conclusion: We report the safe administration of intraventricular rt-PA after endovascular coiling of a ruptured cerebral aneurysm. Two other similar cases were found in the literature and are reviewed. Hindrance of aneurysmal cavity thrombosis by early administration of rt-PA (increasing the risk of rerupture) remains a widespread concern. The lack of such instances should therefore be acknowledged. We propose that inclusion of such patients in trials assessing safety/efficacy of thrombolytic therapy in the treatment of patients with intracranial hemorrhage should be carefully considered.
Similar articles
-
Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.Neurosurgery. 2004 Sep;55(3):532-7; discussion 537-8. doi: 10.1227/01.neu.0000134473.98192.b1. Neurosurgery. 2004. PMID: 15335420
-
Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports.Neurosurgery. 2002 Feb;50(2):421-4; discussion 424-5. doi: 10.1097/00006123-200202000-00037. Neurosurgery. 2002. PMID: 11844282
-
Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.Neurocrit Care. 2015 Dec;23(3):386-93. doi: 10.1007/s12028-015-0126-9. Neurocrit Care. 2015. PMID: 25739904 Clinical Trial.
-
Aneurysmal rupture without subarachnoid hemorrhage: case series and literature review.Neurosurgery. 2005 Aug;57(2):225-9; discussion 225-9. doi: 10.1227/01.neu.0000166535.59056.fa. Neurosurgery. 2005. PMID: 16094149 Review.
-
Intracisternal rt-PA during early surgery for aneurysmal subarachnoid hemorrhage: an Italian report.J Neurosurg Sci. 1993 Jun;37(2):71-5. J Neurosurg Sci. 1993. PMID: 8301373 Review.
Cited by
-
Massive intraventricular haemorrhage from aneurysmal rupture: patient proportions and eligibility for intraventricular fibrinolysis.J Neurol. 2010 Mar;257(3):354-8. doi: 10.1007/s00415-009-5323-z. Epub 2009 Oct 13. J Neurol. 2010. PMID: 19823896 Free PMC article.
-
Management of intraventricular hemorrhage.Curr Neurol Neurosci Rep. 2010 Mar;10(2):73-82. doi: 10.1007/s11910-010-0086-6. Curr Neurol Neurosci Rep. 2010. PMID: 20425231 Free PMC article.
-
Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement.Neurocrit Care. 2011 Aug;15(1):194-209. doi: 10.1007/s12028-010-9390-x. Neurocrit Care. 2011. PMID: 20524079 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical